Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

9.45
+0.14001.50%
Volume:183.74K
Turnover:1.73M
Market Cap:467.77M
PE:-8.18
High:9.51
Open:9.43
Low:9.30
Close:9.31
Loading ...
Jun 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 11, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 10, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 29, 2020

Major Issues Report

8-K - Current report
Apr 09, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Mar 04, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Mar 03, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 18, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 13, 2020

Major Issues Report

Current report, items 1.01, 2.02, 8.01, and 9.01
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 30, 2020

Major Issues Report

Current report, item 5.02
Jan 28, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals